Immuneering News - IMRX

Company Name	Stock Ticker Symbol	Market	Type
Immuneering Corporation	IMRX	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.00	0.00%	1.72	07:00:08

Open Price	Low Price	High Price	Close Price	Prev Close
				1.72

more quote information »

Recent News

Date	Time	Source	Heading
4/22/2024	8:49	IHNW	FeaturedCannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California
4/09/2024	12:00	GLOBE	IMM-1-104 is Synergistic with Chemotherapy in Pancreatic..
4/03/2024	16:05	GLOBE	Immuneering to Participate in the 23rd Annual Needham..
3/27/2024	08:00	GLOBE	Immuneering Announces First Patient Dosed in its Phase 1/2a..
3/14/2024	07:00	GLOBE	Immuneering Announces Positive Topline Results from Phase 1..
3/12/2024	08:00	GLOBE	Immuneering Appoints Thomas J. Schall, Ph.D. to its Board of..
3/11/2024	08:00	GLOBE	Immuneering Doses First Patient in Phase 2a Clinical Trial..
3/05/2024	17:00	GLOBE	Immuneering to Present Preclinical Data on Universal-RAS..
3/04/2024	08:00	GLOBE	Immuneering to Participate in the Cowen 44th Annual Health..
3/01/2024	08:05	EDGAR2	Form 10-K - Annual report [Section 13 and 15(d), not S-K..
3/01/2024	08:00	GLOBE	Immuneering Reports Fourth Quarter and Full Year 2023..
3/01/2024	07:58	EDGAR2	Form 8-K - Current report
2/20/2024	08:00	GLOBE	Immuneering Receives FDA Fast Track Designation for..
2/09/2024	16:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/09/2024	16:26	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/09/2024	16:21	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/09/2024	16:17	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/09/2024	16:12	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/09/2024	16:07	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/02/2024	16:15	EDGAR2	Form 8-K - Current report
1/16/2024	16:37	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
1/02/2024	16:26	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/12/2023	08:00	GLOBE	Immuneering Announces FDA Clearance of IND Application for..
11/20/2023	16:05	GLOBE	Immuneering to Present at the 35th Annual Piper Sandler..
11/09/2023	16:12	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/09/2023	16:05	GLOBE	Immuneering Reports Third Quarter 2023 Financial Results and..
10/12/2023	16:05	GLOBE	Immuneering Presents Preclinical Data Demonstrating..
10/04/2023	16:05	GLOBE	Immuneering to Present Preclinical Data on IMM-1-104 and..
9/06/2023	08:00	GLOBE	Immuneering to Present at the Morgan Stanley Healthcare..
8/03/2023	16:10	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/03/2023	16:05	GLOBE	Immuneering Reports Second Quarter 2023 Financial Results..
8/03/2023	16:04	EDGAR2	Form 8-K - Current report
6/05/2023	08:00	GLOBE	Immuneering Completes Dose Escalation in the IMM-1-104 Phase..
5/30/2023	08:00	GLOBE	Immuneering to Present at the Jefferies Healthcare..
5/04/2023	16:05	GLOBE	Immuneering Reports First Quarter 2023 Financial Results and..